**UPDATE AUGUST 6th**
Dr. Scott Rocklage’s High Level Of Intelligence Has Built An Incredible Career
Dr. Scott Rocklage has achieved many milestones in his career and inspired entrepreneurship and biochemical research. He began his work with 5AM Ventures in 2003 with almost thirty years of experience. His strategies in healthcare are a combination of his scientific experience, background and leadership capabilities. He additionally chairs the Boards for Achaogen, Relypsa, Cidara Therapeutics, Rennovia, Kinestral, and Semprus. He has served prestigious companies in the healthcare field as CEO and his leadership abilities are superb.
Dr. Scott Rocklage’s educational background is impressive. He has earned a Bachelor of Science degree in Chemistry and a Philosophy degree in Chemistry. He worked with Richard R. Schrock, the Nobel Prize Winner in 2005 and was responsible for three new drugs receiving approval from the FDA. Six new drugs are being clinically tested because of Dr. Scott Rocklage. He holds thirty United States Patents and has in excess of 100 publications. Through 5AM Ventures he has studied new aspects regarding life science in addition to working with entrepreneurs. He is working on ways to improve healthcare with medical and scientific advancements.
Dr. Scott Rocklage uses modern techniques to diagnose, treat, and prevent numerous medical conditions. He has been involved with research regarding treating cancer with the use of new advancements and due to his efforts certain genotypes have more than one treatment option. He has contributed to extending the lives of cancer patients. His success is partially attributed to his organizational skills, time management, and prioritization. He firmly believes a companies success is based on the process of selection. He is insistent that when an entrepreneur fails it is connected to the area of management.
Dr. Scott Rocklage has built a reputation for bravery because he shows no fear of measured risks. He does not believe success is about going to work for a Fortune 500 company but based on the decision to become an entrepreneur. He places the success of his current company on their focus to work hard at what they are most qualified for and taking advantage of their strengths in business. This is the strategy that has kept his company successful even in the toughest times instead of the common approach of taking an easier direction. He has thanked the book Good to Great for supplying him with the basis for his career in business and calls the book a timeless tome. He feels it helped him understand performance and business and gives all the credit to the Massachusetts Institute of Technology.
In 2003, Dr. Scott Rocklage joined the 5AM Ventures team and in 2004 he was promoted to Managing Partner. He has over 30 years experience in management in healthcare. His leadership abilities are phenomenal and that landed the FDA approval of three new drugs. They are Omniscan, Cubicin and Teslascan. Dr. Scott Rocklage has held several positions over the course of his career. He served on the board as Chairman and CEO of Cubist Pharmaceuticals, and held numerous positions within the companies of Catalvtica and Salutar. Dr. Scott Rocklage actively is on the board as Chairman of Cidara, Rennovia, Epirus, Pulmatrix, and Kinestral. Dr. Rocklage has created or co-created more than 30 United States patents and over a 100 peer related publications. His office is located in Boston, MA.
He was interviewed by Ideamensch and it offered insight about his background and how the ideas of his business came to be. 5AM Ventures is his business that is based on science and life. For Dr. Rocklage, a typical day varies. Some of his days are spent researching untouched areas of life science and other days are spent working on his management portfolio. And when he’s not doing that, he is attending board meetings.
The ideas that become reality come from the people he works with. Dr. Rocklage works with various scientists, business executives, and physicians to help bring their ideas to life in areas where medical needs have not be touched or treated. One project that has captivated his interest is cancer treatments using mutations in different ways. He wants to save lives or extend patients that has been touched with cancer.
Organization keeps Dr. Rocklage on track with managing his time with the busy schedule he keeps on a daily basis. He was asked what would he change if he could start over again. Dr. Rocklage’s reply was to put more focus on more people. Team selection is imperative when starting a new company and what Scott knows.
Dr. Rocklage has offered advice to entrepreneurs out there and that is to not be afraid of risk-taking. That when you can control your future, you advance further than you would if you worked with an already established company. Stay true to what you can do well and don’t stray from your strengths. The best advice he can give the community is to read this classic book called “Good To Great“. This will help those on the outside understand performance and business.
More visit: https://ideamensch.com/scott-rocklage/